Published in Orphanet J Rare Dis on May 19, 2011
Colony-stimulating factors for febrile neutropenia during cancer therapy. N Engl J Med (2013) 4.20
B cell-helper neutrophils stimulate the diversification and production of immunoglobulin in the marginal zone of the spleen. Nat Immunol (2011) 3.66
High frequency of GATA2 mutations in patients with mild chronic neutropenia evolving to MonoMac syndrome, myelodysplasia, and acute myeloid leukemia. Blood (2012) 1.84
Expression of the secondary granule proteins major basic protein 1 (MBP-1) and eosinophil peroxidase (EPX) is required for eosinophilopoiesis in mice. Blood (2013) 1.72
Classification of and risk factors for hematologic complications in a French national cohort of 102 patients with Shwachman-Diamond syndrome. Haematologica (2012) 1.59
A novel homozygous mutation in G6PC3 presenting as cyclic neutropenia and severe congenital neutropenia in the same family. J Clin Immunol (2013) 1.46
Neutrophil depletion impairs natural killer cell maturation, function, and homeostasis. J Exp Med (2012) 1.39
Neutrophil homeostasis and periodontal health in children and adults. J Dent Res (2013) 1.25
ELANE mutations in cyclic and severe congenital neutropenia: genetics and pathophysiology. Hematol Oncol Clin North Am (2012) 1.14
Natural history of Barth syndrome: a national cohort study of 22 patients. Orphanet J Rare Dis (2013) 1.11
Description and outcome of a cohort of 8 patients with WHIM syndrome from the French Severe Chronic Neutropenia Registry. Orphanet J Rare Dis (2012) 1.01
CLPB mutations cause 3-methylglutaconic aciduria, progressive brain atrophy, intellectual disability, congenital neutropenia, cataracts, movement disorder. Am J Hum Genet (2015) 0.96
Recent insights into inherited bone marrow failure syndromes. Curr Opin Pediatr (2012) 0.88
A clinical and molecular review of ubiquitous glucose-6-phosphatase deficiency caused by G6PC3 mutations. Orphanet J Rare Dis (2013) 0.87
Atypical Chédiak-Higashi syndrome with attenuated phenotype: three adult siblings homozygous for a novel LYST deletion and with neurodegenerative disease. Orphanet J Rare Dis (2013) 0.83
Safeguarding the long-term health of hematopoietic stem cell donors: a continuous and evolving process to maintain donor safety and trust. Expert Rev Hematol (2012) 0.80
Old and new faces of neutropenia in children. Haematologica (2016) 0.79
How I diagnose and treat neutropenia. Curr Opin Hematol (2016) 0.79
Neutropenia in primary immunodeficiency. Curr Opin Hematol (2013) 0.79
The antimicrobial propeptide hCAP-18 plasma levels in neutropenia of various aetiologies: a prospective study. Sci Rep (2015) 0.77
Non-steady-state hematopoiesis regulated by the C/EBPβ transcription factor. Cancer Sci (2015) 0.77
Congenital defects in neutrophil dynamics. J Immunol Res (2014) 0.76
Severe congenital neutropenia due to G6PC3 deficiency: early and delayed phenotype in two patients with two novel mutations. Ital J Pediatr (2014) 0.75
Severe congenital cyclic neutropenia: A case report. Int J Appl Basic Med Res (2016) 0.75
Granulocyte colony-stimulating factor alters the systemic metabolomic profile in healthy donors. Metabolomics (2016) 0.75
Primary immunodeficiencies associated with eosinophilia. Allergy Asthma Clin Immunol (2016) 0.75
Cardiomyopathy in a male patient with neutropenia and growth delay. Ital J Pediatr (2014) 0.75
Clinical spectrum and long-term follow-up of 14 cases with G6PC3 mutations from the French Severe Congenital Neutropenia Registry. Orphanet J Rare Dis (2014) 0.75
Elastase inhibitors as potential therapies for ELANE-associated neutropenia. J Leukoc Biol (2017) 0.75
Comparative Diagnostic Performance of the Granulocyte and Neutrophil Counts. Pract Lab Med (2017) 0.75
WHIM Syndrome With a Novel CXCR4 Variant in a Korean Child. Ann Lab Med (2017) 0.75
Simple mathematical models with very complicated dynamics. Nature (1976) 11.41
Quantitative relationships between circulating leukocytes and infection in patients with acute leukemia. Ann Intern Med (1966) 7.30
Acute myeloid leukemia or myelodysplastic syndrome following use of granulocyte colony-stimulating factors during breast cancer adjuvant chemotherapy. J Natl Cancer Inst (2007) 4.97
Munc13-4 is essential for cytolytic granules fusion and is mutated in a form of familial hemophagocytic lymphohistiocytosis (FHL3). Cell (2003) 4.94
Pyogenic bacterial infections in humans with IRAK-4 deficiency. Science (2003) 4.80
Mutations in SBDS are associated with Shwachman-Diamond syndrome. Nat Genet (2002) 4.62
THE SYNDROME OF PANCREATIC INSUFFICIENCY AND BONE MARROW DYSFUNCTION. J Pediatr (1964) 4.12
Distinct patterns of mutations occurring in de novo AML versus AML arising in the setting of severe congenital neutropenia. Blood (2007) 3.73
Primary immunodeficiencies: 2009 update. J Allergy Clin Immunol (2009) 3.70
Mutations in the gene encoding neutrophil elastase in congenital and cyclic neutropenia. Blood (2000) 3.45
Molecular defects in human severe combined immunodeficiency and approaches to immune reconstitution. Annu Rev Immunol (2004) 3.11
HAX1 deficiency causes autosomal recessive severe congenital neutropenia (Kostmann disease). Nat Genet (2006) 3.03
The neonatal blood count in health and disease. I. Reference values for neutrophilic cells. J Pediatr (1979) 2.98
Registries for robust evidence. JAMA (2009) 2.96
Mutations in the chemokine receptor gene CXCR4 are associated with WHIM syndrome, a combined immunodeficiency disease. Nat Genet (2003) 2.88
A novel human primary immunodeficiency syndrome caused by deficiency of the endosomal adaptor protein p14. Nat Med (2006) 2.85
The incidence of leukemia and mortality from sepsis in patients with severe congenital neutropenia receiving long-term G-CSF therapy. Blood (2006) 2.82
Constitutively activating mutation in WASP causes X-linked severe congenital neutropenia. Nat Genet (2001) 2.70
Analysis of risk factors for myelodysplasias, leukemias and death from infection among patients with congenital neutropenia. Experience of the French Severe Chronic Neutropenia Study Group. Haematologica (2005) 2.66
THE KINETICS OF GRANULOPOIESIS IN NORMAL MAN. Blood (1964) 2.61
Transformation of congenital neutropenia into monosomy 7 and acute nonlymphoblastic leukemia in a child treated with granulocyte colony-stimulating factor. J Pediatr (1995) 2.59
Modulation of adaptive immunity with Toll-like receptors. Semin Immunol (2009) 2.56
Neutrophil granules: a library of innate immunity proteins. Trends Immunol (2007) 2.55
HIV blocked by chemokine antagonist. Nature (1996) 2.50
Mutations in proto-oncogene GFI1 cause human neutropenia and target ELA2. Nat Genet (2003) 2.43
Mutations in ELA2, encoding neutrophil elastase, define a 21-day biological clock in cyclic haematopoiesis. Nat Genet (1999) 2.38
Acute myeloid leukemia and myelodysplastic syndrome after doxorubicin-cyclophosphamide adjuvant therapy for operable breast cancer: the National Surgical Adjuvant Breast and Bowel Project Experience. J Clin Oncol (2003) 2.34
A syndrome with congenital neutropenia and mutations in G6PC3. N Engl J Med (2009) 2.30
A randomized controlled phase III trial of recombinant human granulocyte colony-stimulating factor (filgrastim) for treatment of severe chronic neutropenia. Blood (1993) 2.29
Shwachman-diamond syndrome. Br J Haematol (2002) 2.17
Investigation of the effect of marathon running on leucocyte counts of subjects of different ethnic origins: relevance to the aetiology of ethnic neutropenia. Br J Haematol (2000) 2.16
Severe chronic neutropenia: treatment and follow-up of patients in the Severe Chronic Neutropenia International Registry. Am J Hematol (2003) 2.12
Granulocyte-stimulating factor and severe aplastic anemia: a survey by the European Group for Blood and Marrow Transplantation (EBMT). Blood (2007) 2.09
Prevalence of neutropenia in the U.S. population: age, sex, smoking status, and ethnic differences. Ann Intern Med (2007) 2.07
Incidence of CSF3R mutations in severe congenital neutropenia and relevance for leukemogenesis: Results of a long-term survey. Blood (2006) 2.03
Monocyte function in children with neutropenia and chronic infections. Blood (1972) 1.98
Neutrophil elastase, proteinase 3, and cathepsin G as therapeutic targets in human diseases. Pharmacol Rev (2010) 1.97
Mutations in neutrophil elastase causing congenital neutropenia lead to cytoplasmic protein accumulation and induction of the unfolded protein response. Blood (2006) 1.93
Griscelli syndrome restricted to hypopigmentation results from a melanophilin defect (GS3) or a MYO5A F-exon deletion (GS1). J Clin Invest (2003) 1.93
Mutations of the ELA2 gene found in patients with severe congenital neutropenia induce the unfolded protein response and cellular apoptosis. Blood (2007) 1.92
Autoimmunity in Wiskott-Aldrich syndrome: risk factors, clinical features, and outcome in a single-center cohort of 55 patients. Pediatrics (2003) 1.91
Uncoupling of GTP hydrolysis from eIF6 release on the ribosome causes Shwachman-Diamond syndrome. Genes Dev (2011) 1.89
Targeted next-generation sequencing appoints c16orf57 as clericuzio-type poikiloderma with neutropenia gene. Am J Hum Genet (2009) 1.85
Cohen syndrome is caused by mutations in a novel gene, COH1, encoding a transmembrane protein with a presumed role in vesicle-mediated sorting and intracellular protein transport. Am J Hum Genet (2003) 1.83
Two novel activating mutations in the Wiskott-Aldrich syndrome protein result in congenital neutropenia. Blood (2006) 1.80
Neutrophil elastase in cyclic and severe congenital neutropenia. Blood (2006) 1.74
Mutations in the ELA2 gene correlate with more severe expression of neutropenia: a study of 81 patients from the French Neutropenia Register. Blood (2004) 1.70
The human Shwachman-Diamond syndrome protein, SBDS, associates with ribosomal RNA. Blood (2007) 1.69
Effects of recombinant human granulocyte colony-stimulating factor on neutropenia in patients with congenital agranulocytosis. N Engl J Med (1989) 1.67
NAMPT is essential for the G-CSF-induced myeloid differentiation via a NAD(+)-sirtuin-1-dependent pathway. Nat Med (2009) 1.66
A prospective controlled investigation of prophylactic trimethoprim/sulfamethoxazole in hospitalized granulocytopenic patients. Am J Med (1979) 1.64
Risk factors for evolution of acquired aplastic anemia into myelodysplastic syndrome and acute myeloid leukemia after immunosuppressive therapy in children. Blood (2002) 1.63
Duffy (Fy), DARC, and neutropenia among women from the United States, Europe and the Caribbean. Br J Haematol (2008) 1.61
The Sweet syndrome during therapy with granulocyte colony-stimulating factor. Ann Intern Med (1992) 1.59
Prevalence of mutations in ELANE, GFI1, HAX1, SBDS, WAS and G6PC3 in patients with severe congenital neutropenia. Br J Haematol (2009) 1.59
Infantile genetic agranulocytosis; agranulocytosis infantilis hereditaria. Acta Paediatr Suppl (1956) 1.59
WHIM syndrome, an autosomal dominant disorder: clinical, hematological, and molecular studies. Am J Med Genet (2000) 1.58
Evans syndrome: results of a national survey. J Pediatr Hematol Oncol (1997) 1.56
Myelodysplasia syndrome and acute myeloid leukemia in patients with congenital neutropenia receiving G-CSF therapy. Blood (2000) 1.54
A critical concentration of neutrophils is required for effective bacterial killing in suspension. Proc Natl Acad Sci U S A (2002) 1.52
LEF-1 is crucial for neutrophil granulocytopoiesis and its expression is severely reduced in congenital neutropenia. Nat Med (2006) 1.52
Familial Mediterranean fever at the millennium. Clinical spectrum, ancient mutations, and a survey of 100 American referrals to the National Institutes of Health. Medicine (Baltimore) (1998) 1.50
Peripheral leukocyte count and leukocyte indexes in healthy newborn term infants. J Pediatr (1994) 1.50
Trimethoprim-sulfamethoxazole prophylaxis in the management of chronic granulomatous disease. J Infect Dis (1990) 1.49
Unregulated actin polymerization by WASp causes defects of mitosis and cytokinesis in X-linked neutropenia. J Exp Med (2007) 1.49
Cyclic neutropenia complicated by renal AA amyloidosis. Turk J Pediatr (2000) 1.46
Shwachman-Diamond syndrome: An inherited preleukemic bone marrow failure disorder with aberrant hematopoietic progenitors and faulty marrow microenvironment. Blood (1999) 1.45
"MYELOKATHEXIS"--A NEW FORM OF CHRONIC GRANULOCYTOPENIA. REPORT OF A CASE. N Engl J Med (1964) 1.44
Analysis of a French cohort of patients with large granular lymphocyte leukemia: a report on 229 cases. Haematologica (2010) 1.44
Intermittent hemophagocytic lymphohistiocytosis is a regular feature of lysinuric protein intolerance. J Pediatr (1999) 1.44
Hematological manifestations of copper deficiency: a retrospective review. Eur J Haematol (2008) 1.43
A neutrophil cycle in healthy individuals. Lancet (1966) 1.43
The putative glucose 6-phosphate translocase gene is mutated in essentially all cases of glycogen storage disease type I non-a. Eur J Hum Genet (1999) 1.42
Primary immunodeficiency syndrome in Spain: first report of the National Registry in Children and Adults. J Clin Immunol (1997) 1.41
Resolution of cyclic neutropenia by intramuscular gamma globulin in a case of common variable immunodeficiency with predominantly antibody deficiency. Indian Pediatr (1994) 1.41
Impaired neutrophil activity and increased susceptibility to bacterial infection in mice lacking glucose-6-phosphatase-beta. J Clin Invest (2007) 1.41
The French national registry of primary immunodeficiency diseases. Clin Immunol (2010) 1.40
Determination of the critical concentration of neutrophils required to block bacterial growth in tissues. J Exp Med (2004) 1.38
Nonsense mutations in ADTB3A cause complete deficiency of the beta3A subunit of adaptor complex-3 and severe Hermansky-Pudlak syndrome type 2. Pediatr Res (2002) 1.37
Neutrophil elastase mutations and risk of leukaemia in severe congenital neutropenia. Br J Haematol (2007) 1.37
Reduced-intensity conditioning is effective and safe for transplantation of patients with Shwachman-Diamond syndrome. Bone Marrow Transplant (2008) 1.36
[Lipomatous congenital hypoplasia of the exocrine pancreas in children. (2 cases and review of the literature)]. Arch Fr Pediatr (1961) 1.36
Risk of secondary leukemia after a solid tumor in childhood according to the dose of epipodophyllotoxins and anthracyclines: a case-control study by the Société Française d'Oncologie Pédiatrique. J Clin Oncol (2003) 1.36
Granulocyte colony-stimulating factor preferentially stimulates proliferation of monosomy 7 cells bearing the isoform IV receptor. Proc Natl Acad Sci U S A (2006) 1.36
Reticular dysgenesis (aleukocytosis) is caused by mutations in the gene encoding mitochondrial adenylate kinase 2. Nat Genet (2008) 1.34
Cyclophosphamide-induced cyclical neutropenia. An animal model of a human periodic disease. N Engl J Med (1970) 1.32
Shwachman-Diamond syndrome. Pediatr Blood Cancer (2005) 1.32
Human adenylate kinase 2 deficiency causes a profound hematopoietic defect associated with sensorineural deafness. Nat Genet (2008) 1.31
Frequency and clinical manifestations of patients with primary immunodeficiency disorders in Iran: update from the Iranian Primary Immunodeficiency Registry. J Clin Immunol (2006) 1.30
Novel HAX1 mutations in patients with severe congenital neutropenia reveal isoform-dependent genotype-phenotype associations. Blood (2008) 1.30
X-linked cardioskeletal myopathy and neutropenia (Barth syndrome) (MIM 302060). J Inherit Metab Dis (1999) 1.29
Diagnosis and clinical course of autoimmune neutropenia in infancy: analysis of 240 cases. Blood (1998) 1.27
Diagnostic criteria, clinical characteristics, and natural history of Cohen syndrome. J Med Genet (2003) 1.26
Chediak-Higashi syndrome: a clinical and molecular view of a rare lysosomal storage disorder. Curr Mol Med (2002) 1.24
Exacerbation of pseudogout by granulocyte colony-stimulating factor. Ann Intern Med (1996) 1.22
Predicting the risk of bacteremia in childen with fever and neutropenia. J Clin Oncol (1996) 1.20
Epigenetic regulation of protein-coding and microRNA genes by the Gfi1-interacting tumor suppressor PRDM5. Mol Cell Biol (2007) 1.19
Phagocytosis of neutrophils by marrow macrophages in childhood chronic benign neutropenia. J Pediatr (1981) 1.19
Stable long-term risk of leukaemia in patients with severe congenital neutropenia maintained on G-CSF therapy. Br J Haematol (2010) 1.17
Poikiloderma with neutropenia, Clericuzio type, in a family from Morocco. Am J Med Genet A (2008) 1.16
Hematopoietic stem cell gene therapy with a lentiviral vector in X-linked adrenoleukodystrophy. Science (2009) 8.80
B cell-helper neutrophils stimulate the diversification and production of immunoglobulin in the marginal zone of the spleen. Nat Immunol (2011) 3.66
Analysis of risk factors for myelodysplasias, leukemias and death from infection among patients with congenital neutropenia. Experience of the French Severe Chronic Neutropenia Study Group. Haematologica (2005) 2.66
Munc18-2 deficiency causes familial hemophagocytic lymphohistiocytosis type 5 and impairs cytotoxic granule exocytosis in patient NK cells. J Clin Invest (2009) 2.08
Long-term outcome after hematopoietic stem cell transplantation of a single-center cohort of 90 patients with severe combined immunodeficiency. Blood (2009) 2.03
High frequency of GATA2 mutations in patients with mild chronic neutropenia evolving to MonoMac syndrome, myelodysplasia, and acute myeloid leukemia. Blood (2012) 1.84
Outcome of hematopoietic stem cell transplantation for adenosine deaminase-deficient severe combined immunodeficiency. Blood (2012) 1.80
Proper desensitization of CXCR4 is required for lymphocyte development and peripheral compartmentalization in mice. Blood (2012) 1.74
Mutations in the ELA2 gene correlate with more severe expression of neutropenia: a study of 81 patients from the French Neutropenia Register. Blood (2004) 1.70
Actinomyces in chronic granulomatous disease: an emerging and unanticipated pathogen. Clin Infect Dis (2009) 1.60
Classification of and risk factors for hematologic complications in a French national cohort of 102 patients with Shwachman-Diamond syndrome. Haematologica (2012) 1.59
Ribosomal protein SA haploinsufficiency in humans with isolated congenital asplenia. Science (2013) 1.57
Clinical similarities and differences of patients with X-linked lymphoproliferative syndrome type 1 (XLP-1/SAP deficiency) versus type 2 (XLP-2/XIAP deficiency). Blood (2010) 1.55
Enzyme replacement therapy and/or hematopoietic stem cell transplantation at diagnosis in patients with mucopolysaccharidosis type I: results of a European consensus procedure. Orphanet J Rare Dis (2011) 1.54
A dominant mutation in the gene encoding the erythroid transcription factor KLF1 causes a congenital dyserythropoietic anemia. Am J Hum Genet (2010) 1.50
Additional erythrocytic and reticulocytic parameters helpful for diagnosis of hereditary spherocytosis: results of a multicentre study. Ann Hematol (2010) 1.48
X-linked lymphoproliferative disease due to SAP/SH2D1A deficiency: a multicenter study on the manifestations, management and outcome of the disease. Blood (2010) 1.40
Hematopoietic stem cell transplantation in hemophagocytic lymphohistiocytosis: a single-center report of 48 patients. Pediatrics (2006) 1.39
Neutrophil depletion impairs natural killer cell maturation, function, and homeostasis. J Exp Med (2012) 1.39
Primary immunodeficiency diseases worldwide: more common than generally thought. J Clin Immunol (2012) 1.36
Autosomal dominant STAT3 deficiency and hyper-IgE syndrome: molecular, cellular, and clinical features from a French national survey. Medicine (Baltimore) (2012) 1.31
Hereditary spherocytosis, elliptocytosis, and other red cell membrane disorders. Blood Rev (2013) 1.26
Acute megakaryoblastic leukaemia: a national clinical and biological study of 53 adult and childhood cases by the Groupe Français d'Hématologie Cellulaire (GFHC). Leuk Lymphoma (2003) 1.18
Invasive mold infections in chronic granulomatous disease: a 25-year retrospective survey. Clin Infect Dis (2011) 1.13
Natural history of Barth syndrome: a national cohort study of 22 patients. Orphanet J Rare Dis (2013) 1.11
Complementation of a pathogenic IFNGR2 misfolding mutation with modifiers of N-glycosylation. J Exp Med (2008) 1.06
Engagement of transferrin receptor by polymeric IgA1: evidence for a positive feedback loop involving increased receptor expression and mesangial cell proliferation in IgA nephropathy. J Am Soc Nephrol (2005) 1.04
TTC7A mutations disrupt intestinal epithelial apicobasal polarity. J Clin Invest (2014) 1.02
Description and outcome of a cohort of 8 patients with WHIM syndrome from the French Severe Chronic Neutropenia Registry. Orphanet J Rare Dis (2012) 1.01
A newly identified isoform of Slp2a associates with Rab27a in cytotoxic T cells and participates to cytotoxic granule secretion. Blood (2008) 0.98
Management options for adenosine deaminase deficiency; proceedings of the EBMT satellite workshop (Hamburg, March 2006). Clin Immunol (2007) 0.97
Morbidity and mortality from ataxia-telangiectasia are associated with ATM genotype. J Allergy Clin Immunol (2011) 0.97
Epidemiology and outcome of invasive fungal diseases in patients with chronic granulomatous disease: a multicenter study in France. Pediatr Infect Dis J (2011) 0.97
Hematopoietic stem cell transplantation for de novo erythroleukemia: a study of the European Group for Blood and Marrow Transplantation (EBMT). Blood (2002) 0.95
Failure of bone marrow transplantation to eradicate HIV reservoir despite efficient HAART. AIDS (2007) 0.94
Congenital asplenia in mice and humans with mutations in a Pbx/Nkx2-5/p15 module. Dev Cell (2012) 0.94
First use of thymus transplantation therapy for FOXN1 deficiency (nude/SCID): a report of 2 cases. Blood (2010) 0.94
Longitudinal study assessing the return of chloroquine susceptibility of Plasmodium falciparum in isolates from travellers returning from West and Central Africa, 2000-2011. Malar J (2013) 0.93
Phenotype and genotype for thiopurine methyltransferase activity in the French Caucasian population: impact of age. Eur J Clin Pharmacol (2004) 0.92
Protective effect of IgM against colonization of the respiratory tract by nontypeable Haemophilus influenzae in patients with hypogammaglobulinemia. J Allergy Clin Immunol (2011) 0.92
Lopinavir/ritonavir-based antiretroviral therapy in human immunodeficiency virus type 1-infected naive children: rare protease inhibitor resistance mutations but high lamivudine/emtricitabine resistance at the time of virologic failure. Pediatr Infect Dis J (2011) 0.92
Performance of rapid diagnostic tests for imported malaria in clinical practice: results of a national multicenter study. PLoS One (2013) 0.88
LYST controls the biogenesis of the endosomal compartment required for secretory lysosome function. Traffic (2015) 0.85
Respiratory distress and sudden death of a patient with GSDIb chronic neutropenia: possible role of pegfilgrastim. Haematologica (2009) 0.85
A child with a systemic febrile illness - differential diagnosis and management. Best Pract Res Clin Rheumatol (2006) 0.84
[Infections in splenectomized patient]. Rev Prat (2008) 0.84
Efficacy and safety of thalidomide in patients with inflammatory manifestations of chronic granulomatous disease: a retrospective case series. J Allergy Clin Immunol (2013) 0.83
Therapeutic drug monitoring of voriconazole after intravenous administration in infants and children with primary immunodeficiency. Ther Drug Monit (2011) 0.82
Laronidase for cardiopulmonary disease in Hurler syndrome 12 years after bone marrow transplantation. Pediatrics (2010) 0.82
Neurological findings and genetic alterations in patients with Kostmann syndrome and HAX1 mutations. Pediatr Blood Cancer (2014) 0.80
Severe autoimmune hemolytic anemia caused by a warm IgA autoantibody directed against the third loop of band 3 (RBC anion-exchange protein 1). Transfusion (2002) 0.80
[Chronic granulomatous disease: pathogenesis and therapy of associated fungal infections]. Med Sci (Paris) (2012) 0.79
Defective functions of polymorphonuclear neutrophils in patients with common variable immunodeficiency. Immunol Res (2014) 0.79
Epidemiology of congenital neutropenia. Hematol Oncol Clin North Am (2013) 0.78
[Usefulness of gray platelets observation in ARC syndrome]. Ann Biol Clin (Paris) (2010) 0.78
How can cobalamin injections be spaced in long-term therapy for inborn errors of vitamin B(12) absorption? Mol Genet Metab (2012) 0.78
Cardiomyopathies and congenital heart diseases in Shwachman-Diamond syndrome: a national survey. Int J Cardiol (2012) 0.78
Occurrence of myelodysplastic syndrome in 2 patients with reticular dysgenesis. J Allergy Clin Immunol (2011) 0.78
RAS-associated lymphoproliferative disease evolves into severe juvenile myelo-monocytic leukemia. Blood (2014) 0.77
Childhood craniopharyngioma: greater hypothalamic involvement before surgery is associated with higher homeostasis model insulin resistance index. BMC Pediatr (2009) 0.77
Platelet morphology analysis. Methods Mol Biol (2013) 0.77
LHX2 deregulation by juxtaposition with the IGH locus in a pediatric case of chronic myeloid leukemia in B-cell lymphoid blast crisis. Leuk Res (2012) 0.76
Multicentric Castleman disease in an HHV8-infected child born to consanguineous parents with systematic review. Pediatrics (2011) 0.76
Clinical spectrum and long-term follow-up of 14 cases with G6PC3 mutations from the French Severe Congenital Neutropenia Registry. Orphanet J Rare Dis (2014) 0.75
[Granulopoeisis and leukemogenesis: lessons from congenital neutropenia]. Med Sci (Paris) (2008) 0.75
Corrigendum: Evidence of innate lymphoid cell redundancy in humans. Nat Immunol (2016) 0.75
Vacuolation of neutrophils and acanthocytosis in child with medium chain acyl-CoA dehydrogenase deficiency. Br J Haematol (2008) 0.75
Schistocytes. Transfusion (2014) 0.75
A new lysosomal storage disorder resembling Morquio syndrome in sibs. Eur J Med Genet (2012) 0.75
Evaluation of peroxidase activity by alpha-naphthol/pyronine staining compared with benzidine staining in 101 acute leukemia cases. Lab Hematol (2010) 0.75
A dyserythropoietic anemia associated with homozygous Hb Plasencia [α125(H8)Leu→Arg (α2)] (HBA2:c.377T>G), a variant with an unstable α chain. Hemoglobin (2010) 0.75
Indications and outcomes of antifungal therapy in French patients with haematological conditions or recipients of haematopoietic stem cell transplantation. J Antimicrob Chemother (2012) 0.75